# Effects of different opioids on the contractile tension of isolated rat intestinal smooth muscle

**Authors:** Chen Yang, Jianying Hu, Yan Cheng, Shen Sun, Shaoqiang Huang

PMC · DOI: 10.3389/fphar.2025.1617936 · Frontiers in Pharmacology · 2025-10-27

## TL;DR

This study compares how five opioids affect rat intestinal muscle tension and frequency at different concentrations to identify those with the least gastrointestinal impact.

## Contribution

The study provides a comparative analysis of opioid effects on intestinal smooth muscle contraction in an in vitro rat model.

## Key findings

- Butorphanol showed the strongest inhibition of intestinal contraction tension at lower concentrations.
- Sufentanil and remifentanil significantly reduced tension at higher concentrations.
- Contraction frequency was largely unaffected except at very high sufentanil concentrations.

## Abstract

To compare how five common opioids affect rat intestinal muscle tension and frequency across concentrations, establishing an animal model to provide translational evidence for selecting opioids with the least gastrointestinal impact.

Isolated rat small intestine specimens were prepared, and six intestinal segments were selected from the same rat and placed into remifentanil, sufentanil, oxycodone, nalbuphine, butorphanol, and the control group with balanced solution. Experiments were carried out to observe and compare the changes in the contraction tension and contraction frequency of small intestinal smooth muscle during the change in concentration gradients of 10–9, 10–8, 10–7, 10–6, 10–5, and 10–4 M. Statistical analysis obtained from 10 rats in the in vitro intestinal tube experiment was performed.

The results revealed that when the concentration increased to 10−7 M, the intestinal contraction tension in the butorphanol group began to decrease significantly, and the intestinal contraction tension in the nalbuphine and oxycodone groups began to decrease significantly at concentrations of 10−6 M. while the sufentanil group and the remifentanil group showed a significant decrease in intestinal contractile tension at 10−5 M and 10−4 M, respectively. When the concentration of the drug increased to 10−4 M, the contraction frequency of the sufentanil group decreased significantly, and there was no statistical difference among concentrations of other drugs.

As the concentration increased, different opioids inhibited the contractile tone of rat intestinal smooth muscle in vitro. The intensity of inhibition was butorphanol > nalbuphine ≈ oxycodone > sufentanil > remifentanil, and the Contraction frequency was almost unaffected except in the very high concentration sufentanil group.

## Linked entities

- **Chemicals:** butorphanol (PubChem CID 5361092), nalbuphine (PubChem CID 5311304), oxycodone (PubChem CID 5284603), sufentanil (PubChem CID 41693), remifentanil (PubChem CID 60815)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Diseases:** gastrointestinal (MESH:D005767)
- **Chemicals:** oxycodone (MESH:D010098), remifentanil (MESH:D000077208), nalbuphine   oxycodone (-), butorphanol (MESH:D002077), nalbuphine (MESH:D009266), sufentanil (MESH:D017409)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12598019/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12598019/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12598019/full.md

---
Source: https://tomesphere.com/paper/PMC12598019